No photo of Teresa P. DiLorenzo

View Scopus Profile

Teresa P. DiLorenzo, Ph.D.

  • 2920 Citations
  • 31 h-Index
1989 …2019

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Teresa P. DiLorenzo is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants

An immunotherapeutic strategy for the induction and stabilization of remission in type 1 diabetes

Almo, S. C. & DiLorenzo, T. P.

National Institute of Diabetes and Digestive and Kidney Diseases

9/15/18 → 12/31/18

Project: Research project

    • Structural, functional, and mechanistic anlaysis of autoreactive CD8 T cells

    Almo, S. C. & DiLorenzo, T. P.

    National Institute of Allergy and Infectious Diseases

    2/8/18 → 12/31/18

    Project: Research project

    • CD8 T Cell Epitope Mapping Using Mice Expressing HLA-A2 and a Human Autoantigen

    DiLorenzo, T. P.

    National Institute of Allergy and Infectious Diseases

    4/16/15 → 8/31/15

    Project: Research project

    • T Cell Tolerance by DEC-205-mediated Islet Antigen Delivery to Dendritic Cells

    DiLorenzo, T. P.

    National Institute of Diabetes and Digestive and Kidney Diseases

    9/20/11 → 8/31/12

    Project: Research project

    • T Cell Tolerance by DEC-205-mediated Islet Antigen Delivery to Dendritic Cells

    DiLorenzo, T. P.

    National Institute of Allergy and Infectious Diseases

    6/1/10 → 5/31/12

    Project: Research project

    • Publications

    The evolving landscape of autoantigen discovery and characterization in type 1 diabetes

    Purcell, A. W., Sechi, S. & DiLorenzo, T. P., Jan 1 2019, In : Diabetes. 68, 5, p. 879-886 8 p.

    Research output: Contribution to journal › Article

    Open Access
    • 6 Scopus citations

    HLA-B*39:06 Efficiently Mediates Type 1 Diabetes in a Mouse Model Incorporating Reduced Thymic Insulin Expression

    Schloss, J., Ali, R., Racine, J. J., Chapman, H. D., Serreze, D. V. & DiLorenzo, T. P., May 15 2018, In : Journal of Immunology. 200, 10, p. 3353-3363 11 p.

    Research output: Contribution to journal › Article

    • 3 Scopus citations

    Improved murine MHC-deficient HLA transgenic NOD mouse models for type 1 diabetes therapy development

    Racine, J. J., Stewart, I., Ratiu, J., Christianson, G., Lowell, E., Helm, K., Allocco, J., Maser, R. S., Chen, Y. G., Lutz, C. M., Roopenian, D., Schloss, J., Dilorenzo, T. P. & Serreze, D. V., May 1 2018, In : Diabetes. 67, 5, p. 923-935 13 p.

    Research output: Contribution to journal › Article

    • 4 Scopus citations

    An HLA-transgenic mouse model of type 1 diabetes that incorporates the reduced but not abolished thymic insulin expression seen in patients

    Babad, J., Ali, R., Schloss, J. & DiLorenzo, T. P., 2016, In : Journal of Diabetes Research. 2016, 7959060.

    Research output: Contribution to journal › Article

    • 1 Scopus citations

    Bridging mice to men: Using HLA transgenic mice to enhance the future prediction and prevention of autoimmune type 1 diabetes in humans

    Serreze, D. V., Niens, M., Kulik, J. & DiLorenzo, T. P., May 1 2016, In : Methods in Molecular Biology. 1438, p. 137-151 15 p.

    Research output: Contribution to journal › Review article

    • 6 Scopus citations